Early changes in the components of the metabolic syndrome in a group of smokers after tobacco cessation

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 4, 2014, Pages 242-250

  Ponciano Rodriguez, Guadalupe ^a,b   Paez Martinez, Nayeli ^b,c   Villa Romero, Antonio ^a   Gutierrez Grobe, Ylse ^c   Mendez Sanchez, Nahum ^d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^d LIVER RESEARCH UNIT   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; VARENICLINE; GLUCOSE BLOOD LEVEL; NICOTINE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT INDEX; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT GAIN; ADOLESCENT; AGED; ANALYSIS; COMPLICATION; METABOLISM; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARBON MONOXIDE; CHOLESTEROL, HDL; COGNITIVE THERAPY; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NICOTINE; PREVALENCE; SMOKING; SMOKING CESSATION; WAIST CIRCUMFERENCE; WEIGHT GAIN; YOUNG ADULT;

EID: 84898969191     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2014.0007     Document Type: Article

References (50)

1. World Health Organization. Tobacco. Fact sheet no. 339. Geneva: World Health Organization, 2013.
2. Jime'nez-Ruiz JA, Sa'enz de Miera B, Reynales-Shigematsu LM et al. The impact of taxation on tobacco consumption in Mexico. Tob Control 2008;17:105-110.
3. Jha P, Ramasundarahettige C, Landsman V, et al. 21stcentury hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368:341-50.
4. Farley AC, Hajek P, Lycett D, et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 2012;1:CD006219.
5. Filozof C, Fernandez Pinilla MC, Fernandez-Cruz A. Smoking cessation and weight gain. Obes Rev 2004;5:95-103.
6. Feldstein AC, Nichols GA, Smith DH, et al. Weight change in diabetes and glycemic and blood pressure control. Diabetes Care 2008;31:1960-1965.
7. Gerace TA, Hollis J, Ockene JK, et al. Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group. Prev Med 1991;20: 602-620.
8. Grundy SM, Brewer HB, Jr., Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438.
9. Balkau B, Valensi P, Eschwege E, et al. A review of the metabolic syndrome. Diabetes Metab 2007;33:405-413.
10. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study. Diabetes Care 2003;26:3153-3159.
11. Scuteri A, Najjar SS, Morrell CH, et al. The metabolic syndrome in older individuals: Prevalence and prediction of cardiovascular events: The Cardiovascular Health Study. Diabetes Care 2005;28:882-887.
12. Aguilar-Salinas CA, Lerman-Garber I, Perez J, et al. Lipids, apoprotein B, and associated coronary risk factors in urban and rural older Mexican populations. Metabolism 2001;50:311-318.
13. Gonzalez C, Stern MP, Gonzalez E, et al. The Mexico City Diabetes Study: A population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes. Nutr Rev 1999;57: S71-S76.
14. Nichaman MZ, Garcia G. Obesity in Hispanic Americans. Diabetes Care 1991;14:691-694.
15. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res 2004;35:76-81.
16. Rojas R, Aguilar-Salinas CA, Jimenez-Corona A, et al. Metabolic syndrome in Mexican adults: Results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010;52(Suppl 1):S11-S18.
17. Facchini FS, Hollenbeck CB, Jeppesen J, et al. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-1130.
18. He Y, Lam TH, Jiang B, et al. Combined effects of tobacco smoke exposure and metabolic syndrome on cardiovascular risk in older residents of China. J Am Coll Cardiol 2009; 53:363-371.
19. Ishizaka N, Ishizaka Y, Toda E, et al. Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by the Japanese criteria. Intern Med 2007;46:1167-1170.
20. Oh SW, Yoon YS, Lee ES, et al. Association between cigarette smoking and metabolic syndrome: The Korea National Health and Nutrition Examination Survey. Diabetes Care 2005;28:2064-2066.
21. Miyatake N, Wada J, Kawasaki Y, et al. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med 2006;45:1039-1043.
22. Weitzman M, Cook S, Auinger P, et al. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation 2005;112:862-869.
23. Cena H, Tesone A, Niniano R, et al. Prevalence rate of metabolic syndrome in a group of light and heavy smokers. Diabetol Metab Syndr 2013;5:28.
24. Fukuyama N, Homma K, Wakana N, et al. Validation of the Friedewald Equation for Evaluation of Plasma LDLCholesterol. J Clin Biochem Nutr 2008;43:1-5.
25. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
26. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (Adult Panel Treatment III). NIH Publication No. 01-3670. May 2001. National Institutes of Health, 2013.
27. Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 1999;28:319-26.
28. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009; 373:1083-1096.
29. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4-beta2 nicotinic acetyl- choline receptor partial agonist, vs sustained- release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA 2006; 296:47-55.
30. Perkins AK. Issues in the prevention of weight gain after smoking cessation. Ann Behav Med 1994;16:46-52.
31. Aubin HJ, Farley A, Lycett D, et al. Weight gain in smokers after quitting cigarettes: Meta-analysis. Br Med J 2012;345:e4439.
32. Jeffery RW, Hennrikus DJ, Lando HA, et al. Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation. Health Psychol 2000;19: 242-246.
33. O'Hara P, Connett JE, Lee WW, et al. Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol 1998;148:821-830.
34. Mackay DF, Gray L, Pell JP. Impact of smoking and smoking cessation on overweight and obesity: Scotlandwide, cross-sectional study on 40,036 participants. BMC Public Health 2013;13:348.
35. Akbartabartoori M, Lean ME, Hankey CR. Relationships between cigarette smoking, body size and body shape. Int J Obes (Lond) 2005;29:236-243.
36. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
37. Visser M, Launer LJ, Deurenberg P, et al. Past and current smoking in relation to body fat distribution in older men and women. J Gerontol A Biol Sci Med Sci 1999;54:M293- M298.
38. Lissner L, Bengtsson C, Lapidus L, et al. Smoking initiation and cessation in relation to body fat distribution based on data from a study of Swedish women. Am J Public Health 1992;82:273-275.
39. Komiya H, Mori Y, Yokose T, et al. Smoking as a risk factor for visceral fat accumulation in Japanese men. Tohoku J Exp Med 2006;208:123-132.
40. Bazzano LA, He J, Muntner P, et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003;138: 891-897.
41. Primatesta P, Falaschetti E, Gupta S, et al. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 2001;37:187-193.
42. Aguilar-Salinas CA, Olaiz G, Valles V, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001;42:1298-1307.
43. Direccion General de Epidemiolog?'a. National Statistics on Mortality. Me'xico: Secretaria de Salud, 2012.
44. Yeh H-Ch, Duncan BB, Schmidt MI, et al., Smoking, smoking cessation, and risk for type 2 diabetes. A cohort study. Ann Intern Med 2010; 152:10-17.
45. Tobias KD, Pan A, Jackson CL, et al., Body-mass index and mortality among adult with incident type 2 diabetes. N Engl J Med 2014;370:233-244.
46. Criqui MH, Wallace RB, Heiss G, et al. Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation 1980;62(4 Pt 2):IV70-IV76.
47. Ghali WA, Rodondi N. HDL cholesterol and cardiovascular risk. Br Med J 2009;338:a3065.
48. Facchini FS. The Metabolic Syndrome X. Insulin Resistance in Smokers. New Jersey: Humana Press,1999.
49. Assali AR, Beigel Y, Schreibman R, et al. Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol 1999;22:357-360.
50. Tamura U, Tanaka T, Okamura T et al., Changes in weight, cardiovascular risk factors and estimated risk of coronary heart disease following smoking cessation in Japanese male workers: HIPOP-OHP study. J Atheroscler Thromb 2010; 17:12-20.